title: A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia.
abstract: BACKGROUND
  There have not been any reports in Japan clarifying the efficacy and safety of intramuscular (IM) olanzapine and IM levomepromazine in agitated elderly patients with schizophrenia. This study was a comparative investigation of the clinical efficacy and safety of IM olanzapine and IM levomepromazine in agitated elderly patients with schizophrenia at 2 hours post-dose.
  
  
  METHODS
  The subjects were 52 inpatients who were diagnosed with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. Their clinical symptoms were assessed using the Positive and Negative Syndrome Scale Excited Component (PANSS-EC), PANSS, and Agitation Calmness Evaluation Scale (ACES), and their safety was assessed using the Abnormal Involuntary Movement Scale (AIMS), Barnes Akathisia Rating Scale (BARS), Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS), and glucose test.
  
  
  RESULTS
  The PANSS-EC total score, the ACES score, and the glucose level significantly decreased from baseline in both the IM olanzapine group and the levomepromazine injection group; however, no between-group differences were observed. Mean change from baseline in the PANSS total score, positive score, the BARS score, and the DIEPSS total score was significantly greater in the IM olanzapine injection group compared with the levomepromazine injection group.
  
  
  CONCLUSIONS
  The results of this study suggest that agitated elderly patients rapidly respond to IM olanzapine and IM levomepromazine treatment. Furthermore, these results suggest that IM olanzapine is safer than IM levomepromazine and causes greater improvement in positive symptoms.
authors.affiliation: Department of Psychiatry, Suzuki Clinic, Tokyo, Japan.
authors.forename: Hidenobu
authors.initials: H
authors.lastname: Suzuki
authors.forename: Keishi
authors.initials: K
authors.lastname: Gen
keywords: acute agitation; elderly schizophrenia; intramuscular levomepromazine; intramuscular olanzapine; positive symptoms; safety
references.citation: Clin Pharmacokinet. 1999 Dec;37(6):435-56
references.pmid: 10628896
references.citation: J Clin Psychopharmacol. 1982 Aug;2(4):274-7
references.pmid: 7119135
references.citation: Drug Saf. 2000 Sep;23(3):215-28
references.pmid: 11005704
references.citation: J Clin Psychopharmacol. 2001 Jun;21(3):257-61
references.pmid: 11386487
references.citation: Eur J Clin Pharmacol. 2010 Sep;66(9):911-7
references.pmid: 20521034
references.citation: J Clin Psychopharmacol. 2010 Jun;30(3):230-4
references.pmid: 20473056
references.citation: Pharmacopsychiatry. 1998 Jul;31(4):126-30
references.pmid: 9754846
references.citation: Arch Gen Psychiatry. 1989 Oct;46(10):914-8
references.pmid: 2572206
references.citation: Br J Psychiatry. 1989 May;154:672-6
references.pmid: 2574607
references.citation: J Clin Psychiatry. 1987 Sep;48 Suppl:13-9
references.pmid: 2887552
references.citation: West J Emerg Med. 2012 Feb;13(1):26-34
references.pmid: 22461918
references.citation: Eur Psychiatry. 2012 May;27(4):234-9
references.pmid: 20620029
references.citation: Am J Psychiatry. 1993 Oct;150(10):1561-2
references.pmid: 8104390
references.citation: J Clin Psychiatry. 2008 Dec;69(12):1869-79
references.pmid: 19192477
references.citation: J Clin Psychiatry. 1998;59 Suppl 19:5-8
references.pmid: 9847046
references.citation: Curr Med Res Opin. 2004 Dec;20(12):1877-81
references.pmid: 15701205
references.citation: Int Clin Psychopharmacol. 1995 Sep;10 Suppl 3:105-14
references.pmid: 8866772
references.citation: J Psychiatr Pract. 2005 Nov;11 Suppl 1:5-108; quiz 110-2
references.pmid: 16319571
references.citation: Schizophr Bull. 1990;16(3):537-45
references.pmid: 2287938
references.citation: Am J Psychiatry. 2001 Jul;158(7):1149-51
references.pmid: 11431240
references.citation: Schizophr Bull. 1987;13(2):261-76
references.pmid: 3616518
references.citation: Am J Psychiatry. 1997 Apr;154(4 Suppl):1-63
references.pmid: 9090368
references.citation: Lancet. 2000 Mar 25;355(9209):1048-52
references.pmid: 10744090
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):401-5
references.pmid: 20079791
references.citation: Cochrane Database Syst Rev. 2010 Oct 06;(10):CD007779
references.pmid: 20927765
references.citation: Anesthesiology. 1980 Dec;53(6):494-7
references.pmid: 7457966